Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MannKind Corp MNKD

Healthcare Biotechnology
MannKind Corporation is a biopharmaceutical company. It is focused on the development and commercialization of inhaled therapeutic products for patients with endocrine and orphan lung diseases. Its technologies include Technosphere dry-powder formulations and Dreamboat inhalation devices, which offers delivery of medicines to the deep lung where they can exert an effect locally or enter the... see more

Recent & Breaking News (NDAQ:MNKD)

20 Stocks Moving In Thursday's Pre-Market Session

Benzinga.com  May 11, 2017

MannKind Corporation Reports 2017 First Quarter Financial Results

GlobeNewswire May 10, 2017

Investor Network: MannKind Corporation to Host Earnings Call

Accesswire May 10, 2017

Biotech Stocks Under Scanner -- Bioverativ, Zosano Pharma, MannKind, and Ocera Therapeutics

PR Newswire May 10, 2017

MannKind and One Drop to collaborate on delivering better health outcomes for people with diabetes

GlobeNewswire May 4, 2017

MannKind Corporation to Hold 2017 First Quarter Financial Results Conference Call on May 10, 2017

GlobeNewswire April 28, 2017

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  April 7, 2017

Biotech Stocks Under Scanner -- MannKind, Opko Health, Celgene, and Array BioPharma

PR Newswire March 20, 2017

Watch These 8 Huge Put Purchases In Monday Trade

Benzinga.com  March 20, 2017

MannKind Corporation Reports 2016 Fourth Quarter and Full Year Financial Results

GlobeNewswire March 16, 2017

MannKind Corporation and Charles Mattocks Announce “REVERSED”-America’s First Docu-Series Tackling Diabetes

GlobeNewswire March 8, 2017

MannKind Corporation Announces Upcoming Events

GlobeNewswire March 7, 2017

15 Biggest Mid-Day Losers For Monday

Benzinga.com  March 6, 2017

MannKind Receives $16.7 Million From Sale of Valencia Property 

GlobeNewswire February 21, 2017

Biotech Stocks Under Scanner -- Mast Therapeutics, MannKind, Celgene, and Opko Health

PR Newswire February 3, 2017

MannKind Announces Launch of New Titration Pack and Field Force Expansion to Accelerate Afrezza® Growth

GlobeNewswire February 1, 2017

MannKind Corporation to Hold Investor Conference Call on February 1, 2017

GlobeNewswire January 27, 2017

FinancialBuzz.com: Advances in Biotechnology Sector

PR Newswire January 9, 2017

MannKind Receives $30.6 Million From Sanofi

GlobeNewswire January 9, 2017

CORRECTING AND REPLACING -- MannKind Corporation to Present at the J.P. Morgan 2017 Healthcare Conference

GlobeNewswire January 5, 2017